14
Participants
Start Date
December 31, 2015
Primary Completion Date
May 31, 2016
Study Completion Date
May 31, 2016
Autologous apheresis Platelet Components, prepared with the INTERCEPT Blood System for Platelets.
Each subject will provide two apheresis platelet donations (one per period) and receive two infusions (one per period) of autologous radiolabeled fresh platelets combined with INTERCEPT treated platelet components stored for either 6 or 7 days (approximately 10 to 30 mL). Platelets are administered by intravenous infusion in a peripheral vein via 19-gauge butterfly infusion needle.
Autologous apheresis Conventional untreated Platelet Components
Each subject will provide two apheresis platelet donations (one per period) and receive two infusions (one per period) of autologous radiolabeled fresh platelets combined with conventional untreated platelet components stored for either 6 or 7 days (approximately 10 to 30 mL). Platelets are administered by intravenous infusion in a peripheral vein via 19-gauge butterfly infusion needle.
Hoxworth Blood Center, Cincinnati
Dartmouth-Hitchcock Medical Center, Lebanon
Lead Sponsor
Cerus Corporation
INDUSTRY